These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


105 related items for PubMed ID: 6175461

  • 1. Evaluation of the human interferon system in viral disease.
    Levin S, Hahn T.
    Clin Exp Immunol; 1981 Dec; 46(3):475-83. PubMed ID: 6175461
    [Abstract] [Full Text] [Related]

  • 2. Interferon deficiency syndrome.
    Levin S, Hahn T.
    Clin Exp Immunol; 1985 May; 60(2):267-73. PubMed ID: 2408800
    [Abstract] [Full Text] [Related]

  • 3. Treatment of life-threatening viral infections with interferon alpha: pharmacokinetic studies in a clinical trial.
    Levin S, Hahn T, Rosenberg H, Bino T.
    Isr J Med Sci; 1982 Apr; 18(4):439-46. PubMed ID: 6177663
    [Abstract] [Full Text] [Related]

  • 4. [The interferon system. A review of biological principles and clinical uses].
    Schneider FJ.
    Z Gesamte Inn Med; 1986 Nov 15; 41(22):613-8. PubMed ID: 2436387
    [Abstract] [Full Text] [Related]

  • 5. Increased virus replication in mammalian cells by blocking intracellular innate defense responses.
    de Vries W, Haasnoot J, van der Velden J, van Montfort T, Zorgdrager F, Paxton W, Cornelissen M, van Kuppeveld F, de Haan P, Berkhout B.
    Gene Ther; 2008 Apr 15; 15(7):545-52. PubMed ID: 18273055
    [Abstract] [Full Text] [Related]

  • 6. The interferon response circuit in antiviral host defense.
    Haller O, Weber F.
    Verh K Acad Geneeskd Belg; 2009 Apr 15; 71(1-2):73-86. PubMed ID: 19739399
    [Abstract] [Full Text] [Related]

  • 7. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
    Korth MJ, Taylor MD, Katze MG.
    Virology; 1998 Aug 01; 247(2):265-73. PubMed ID: 9705919
    [Abstract] [Full Text] [Related]

  • 8. [Human interferons -- features and chances (author's transl)].
    Pohl A, Moser K, Micksche M.
    Wien Klin Wochenschr; 1981 Jul 10; 93(14):439-57. PubMed ID: 6168122
    [Abstract] [Full Text] [Related]

  • 9. Deficient interferon-alpha response of newborns in comparison to adults.
    Neustock P, Kruse A, Bock S, St Pierre B, Kirchner H.
    Lymphokine Cytokine Res; 1993 Apr 10; 12(2):109-14. PubMed ID: 8391859
    [Abstract] [Full Text] [Related]

  • 10. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
    Billiau A.
    J Pharmacol; 1983 Apr 10; 14 Suppl 3():105-16. PubMed ID: 6200731
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
    Okuse C, Rinaudo JA, Farrar K, Wells F, Korba BE.
    Antiviral Res; 2005 Jan 10; 65(1):23-34. PubMed ID: 15652968
    [Abstract] [Full Text] [Related]

  • 12. [The first answer to viral infections: type I interferon].
    Pichlmair A, Pollak M, Bergthaler A.
    Berl Munch Tierarztl Wochenschr; 2004 Jan 10; 117(7-8):252-65. PubMed ID: 15298051
    [Abstract] [Full Text] [Related]

  • 13. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL.
    APMIS Suppl; 2003 Jan 10; (114):1-37. PubMed ID: 14626050
    [Abstract] [Full Text] [Related]

  • 14. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH.
    Hepatogastroenterology; 1997 Jan 10; 44(14):417-25. PubMed ID: 9164512
    [Abstract] [Full Text] [Related]

  • 15. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
    Hagelstein J, Kist A, Stremmel W, Galle PR.
    Arzneimittelforschung; 1998 Mar 10; 48(3):343-7. PubMed ID: 9553691
    [Abstract] [Full Text] [Related]

  • 16. Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response.
    Young DF, Didcock L, Goodbourn S, Randall RE.
    Virology; 2000 Apr 10; 269(2):383-90. PubMed ID: 10753717
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interferon-induced Mx proteins in antiviral host defense.
    Haller O, Staeheli P, Kochs G.
    Biochimie; 2007 Apr 10; 89(6-7):812-8. PubMed ID: 17570575
    [Abstract] [Full Text] [Related]

  • 19. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.
    Liu WJ, Wang XJ, Clark DC, Lobigs M, Hall RA, Khromykh AA.
    J Virol; 2006 Mar 10; 80(5):2396-404. PubMed ID: 16474146
    [Abstract] [Full Text] [Related]

  • 20. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A, Parlato A, Vangieri B, Bresciani M, Derna R.
    Clin Ter; 2006 Mar 10; 157(4):377-86. PubMed ID: 17051976
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.